期刊文献+

应用OCT观察Lucentis治疗视网膜静脉阻塞性黄斑水肿的疗效 被引量:3

The Clinical Study on Intravitreous Injection of Lucentis For Macular Edema in Retinal Vein Occlusion by OCT
下载PDF
导出
摘要 目的:观察玻璃体腔注射Lucentis治疗视网膜静脉阻塞继发黄斑水肿的疗效。方法:回顾性分析玻璃体腔注射Lucentis治疗视网膜静脉阻塞性黄斑水肿患者44例(44眼),定期随访6个月。观察治疗前及治疗后1d,2周,1、3、6个月时最佳矫正视力,OCT显示的黄斑中心凹厚度变化及并发症。结果:Lucentis玻璃体腔注射2周,1、3、6个月平均最佳矫正视力均提高,差异有统计学意义(P<0.05)。随访中未见与注射及药物有关的眼部及全身不良反应。结论:Lucentis玻璃体腔注射治疗视网膜静脉阻塞引起的黄斑水肿安全有效,操作简单,必要时可重复注射治疗。 Objective: To observe the curative effect of intravitreal injection of Lucentis for treatment of retinal vein occlusion(RVO) with macular edema(ME). Methods: This is a retrospective study on 44 cases (44 eyes) with macular edema induced by RVO. All of the patients received intravitreous injection of lucentis, andwere regular followed up for 6 months. To observe the BCVA, CMT and complications before injection and 1 day, 2 weeks, and 1,3, 6months after initial injection. Results:The mean BCVA was significantly improved at 2 weeks and 1, 3, 6 months after injection in comparison with before injection(p 〈 0.05). No ocular or systemic adverse events were found after intravitreal injection of lucentis during the follow- up duration. Conclusion: In- travitreous injection of lucentis for ME in RVO is safe, effective and simole operation.
作者 李臻
出处 《内蒙古医学杂志》 2013年第10期1167-1170,F0004,共5页 Inner Mongolia Medical Journal
关键词 LUCENTIS 视网膜静脉阻塞 黄斑水肿 Lucentis Retinalvein occlusion Macular edema
  • 引文网络
  • 相关文献

参考文献11

  • 1Mitchell P,Smith W,Chang A. Prevalence and associations of retinalvein occlusion in Australia[J].{H}Archives of Ophthalmology,1996.1243-1247. 被引量:1
  • 2于同利,毕宏生.Avastin在眼科应用的研究进展[J].国际眼科杂志,2008,8(4):810-812. 被引量:23
  • 3李夏,王雨生.Bevacizumab治疗脉络膜新生血管疾病的现状[J].中国实用眼科杂志,2006,24(11):1112-1115. 被引量:10
  • 4Mcallister IL,Douglas JP,Constable IJ. Laser-induced chorioretinal venous anastomosis for nonischeanic central retinal vein occlusion[J].{H}American Journal of Ophthalmology,1998,(03):219-229. 被引量:1
  • 5Mathias A,Christoph T,U te W. Treatment of branch retinal vein occlusion induced macular edema with bevacizumab[J].{H}Graefes Arch Clinical experimental Ophthalmolgy,2009.27-33. 被引量:1
  • 6Noma H,Minamoto A,Funatsu H. Intravitreal levels of vascular endothelial growth factor and interleukin-6 are correlated with macular edema in branch retinal vein occlusion[J].{H}Graefes Arch Clinical experimental Ophthalmolgy,2006,(03):309-315. 被引量:1
  • 7Noma H,Funatsu H,Yamasaki M. Pathogenesis of macular edema with branch retinal vein occlusion and intraocular levels of vascular endothelial growth factor and interleukin-6[J].{H}American Journal of Ophthalmology,2005,(02):256-261. 被引量:1
  • 8徐海峰,董晓光,王伟,陈焓.玻璃体内注射曲安奈德治疗黄斑水肿[J].中华眼底病杂志,2005,21(4):205-208. 被引量:59
  • 9Volpert OV,Zaichuk T,Zhou W. Inducer-stimulated Fas targets activated endothelium for destruction by anti-angiogenic thmmbospondin-1 and pigment epithelium-derived factor[J].{H}Nature Medicine,2002,(04):349-357. 被引量:1
  • 10Diabetic Retinopathy Clinical Research Network. A randomized trial comparing intravitreal triameinolone acetonide and focal grid Photocoagulation for diabetic macular edema[J].{H}OPHTHALMOLOGY,2008,(14):47-59. 被引量:1

二级参考文献72

  • 1杨秀梅,王雨生,惠延年.外源性脉络膜新生血管抑制剂的研究进展[J].眼科新进展,2005,25(1):75-78. 被引量:8
  • 2周洪伟,吴强.血管内皮生长因子及其受体与眼底新生血管[J].国际眼科杂志,2007,7(3):791-795. 被引量:17
  • 3Klein R, Klein BEK, Moss SE, et al. The Wisconsin epidemiologic study of diabetic retinopathy Ⅳ:diabetic macular edema. Ophthalmology, 1984,91:1464-1474. 被引量:1
  • 4Durrani OM, Meads CA, Murray PI. Uveitis: a potentially blinding disease. Ophthalmologica, 2004,218:223-236. 被引量:1
  • 5Bresnick GH. Diabetic maculopathy: a critical review highlighting diffuse macular edema. Ophthalmology, 1983,90:1301-1317. 被引量:1
  • 6Martidis A, Duker JS, Greenberg PB, et al. Intravitreal triamcinolone for refractory diabetic macular edema.Ophthalmology, 2002,109: 920-927. 被引量:1
  • 7Jonas JB, Kreissig I, Sofker A, et al. Intravitreal injection of triamcinolone for diffuse diabetic macular edema. Arch Ophthalmol, 2003,121: 57-61. 被引量:1
  • 8Otani T, Kishi S, Maruyama Y. Patterns of diabetic macula edema with optical coherence tomography. Am J Ophthalmol,1999,127:688-693. 被引量:1
  • 9Jonas JB, Kreissig I, Degenring RF. Intrvitreal triamcinolone acetonide as treatment of macular edema in central retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol, 2002, 240: 782-783. 被引量:1
  • 10Benhamou N, Massia P, Haouchine B, et al. Intravitreal triamcinolone for refractory pseudophakic macular edema. Am J Ophthalmol, 2003,135: 246-249. 被引量:1

共引文献87

同被引文献36

  • 1赵堪兴.眼科学[M].第8版,北京:人民卫生出版社,2013,176. 被引量:25
  • 2Ladaique M, Dirani A, Ambresin A. Long-term follow-up of choroidal neovascularization in pathological myopia treated with intravitreal ranibizumab [J]. Klin Monbl Augenheilkd, 2015, 232(4) : 542-547. 被引量:1
  • 3Loutfi M, Siddiqui MR, Dhedhi A, et al. A systematic review and meta-analysis comparing intravitreal ranibizumab with bev- acizumab for the treatment of myopic choroidal neovascularisa- tion[J]. Saudi J Ophthalmol, 2015, 29(2) : 147-155. 被引量:1
  • 4Adatia FA, Luong M, Munro M, et al. The other CNVM: a review of myopic choroidal neovascularization treatment in the age of anti-vascular endothelial growth factor agents[J]. Surv Ophthalmol, 2015, 60(3):204-215. 被引量:1
  • 5杜军辉,李夏,成静.光动力疗法联合血管内皮生长因子抑制剂及糖皮质激素治疗脉络膜新生血管疾病的研究进展[J].中华临床医师杂志,2013,7(15):7180-7185. 被引量:1
  • 6Saitta A, Nicolai M, Neri P, et al. Rescue therapy with intrav- itreal aflibereept for choroidal neovascularization secondary to ehoroidal osteoma non-responder to intravitreal bevacizumab and ranibizumab [J]. Int Ophthalmol, 2015, 35(3):441-444. 被引量:1
  • 7Veloso CE, Schmidt-Erfurth U, Nehemy MB. Choroidal neo- vascularization induced by immunogenie alteration of the retinal pigment epithelium in dengue fever [J]. Case Rep Ophthalmol, 2015, 6(1):18-23. 被引量:1
  • 8Byon IS, Kwon HJ, Kim SI, et al. Reduced-fluence photody- namic therapy in polypoidal choroidal vasculopathy nonrespons- ire to ranibizumab [J]. Ophthalmic Surg Lasers Imaging Reti- na, 2014, 45(6):534-541. 被引量:1
  • 9Claxton L, Malcolm B, Taylor M, et al. Ranibizumab, verte- porfin photodynamic therapy or observation for the treatment of myopic choroidal neovascularization: cost effeetiveness in the UK[J]. Drugs Aging, 2014, 31(11): 837-848. 被引量:1
  • 10Sayanagi K, Gomi F, Akiba M, et al. En-face high-penetration optical coherence tomography imaging in polypoidal choroidal vasculopathy[J]. Br J Ophthalmol, 2015, 99(1) :29-35. 被引量:1

引证文献3

二级引证文献23

相关主题

;
使用帮助 返回顶部